ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

Why Extrapulmonary Neuroendocrine Cancer (epNEC) is on this study

  • ClinicalTrials.gov filed the study under Extrapulmonary Neuroendocrine Cancer (epNEC); it no longer does.
  • Rule based: not read yet.
4 links0 made here, not in the record4 judgments1 judge (the rules as one: Rule based)4 record changes seen
Rule basedRecord updated on ClinicalTrials.gov
Sep 28Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16Nov 23TodayNCT07544654DAREON®-NEC-1: A Study inPeople With AdvancedExtrapulmonaryNeuroendocrine Cancer(epNEC) to CompareObrixtamig Plus Carboplatinand Etoposide TreatmentBoehringer IngelheimPhase 3 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Sep 29 · ClinicalTrials.gov record · Version of 2026-09-29Oct 13 · ClinicalTrials.gov record · Version of 2026-10-13Oct 28 · ClinicalTrials.gov record · Version of 2026-10-28Nov 10 · ClinicalTrials.gov record · Version of 2026-11-10Version of 2026-11-10CONDITIONSExtrapulmonary Neuroendocri…No longer in the registry's filing›Nov 14 · Rule based · Not readNot readDRUGSObrixtamigIntervention entry›As of now · Rule based · TestedTestedCarboplatinIntervention entry›As of now · Rule based · BackgroundBackgroundEtoposideIntervention entry›As of now · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
4 versions of the record seen on ClinicalTrials.gov, Sep 29–Nov 10 · changes seen, not judgments
Nov 14Extrapulmonary Neuroendocrine Cancer (epNEC)Rule based · condition-kind ruleNot readCurrent
As of nowObrixtamigRule based · role ruleTestedCurrent
As of nowCarboplatinRule based · role ruleBackgroundCurrent
As of nowEtoposideRule based · role ruleBackgroundCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.